Bausch Health
BHC
334 hedge funds and large institutions have $3.54B invested in Bausch Health in 2018 Q4 according to their latest regulatory filings, with 60 funds opening new positions, 96 increasing their positions, 109 reducing their positions, and 55 closing their positions.
3.89% more ownership
Funds ownership: 50.97% → 54.86% (+3.9%)
9% more first-time investments, than exits
New positions opened: 60 | Existing positions closed: 55
1% more funds holding
Funds holding: 332 → 334 (+2)
12% less repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 109
17% less funds holding in top 10
Funds holding in top 10: 12 → 10 (-2)
23% less capital invested
Capital invested by funds: $4.59B → $3.54B (-$1.05B)
49% less call options, than puts
Call options by funds: $365M | Put options by funds: $716M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
+$77.8M |
| 2 |
GCM
Glenview Capital Management
New York
|
+$72.8M |
| 3 |
O
OrbiMed
New York
|
+$40.4M |
| 4 |
Parallax Volatility Advisers
San Francisco,
California
|
+$37.1M |
| 5 |
AAM
Ardevora Asset Management
London,
United Kingdom
|
+$37M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$41M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$34.1M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$31.4M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$29.2M |
| 5 |
JP Morgan Chase
New York
|
-$28.8M |
BHC Hedge Fund Activity: Q4 2018 in Review
334 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q4 2018, worth a combined $3.54B — down 23% from $4.59B a quarter earlier.
Buyers outnumbered sellers: 60 funds opened new BHC positions and 55 closed out — a net gain of 5 holders — while 96 added to existing stakes and 109 trimmed.
The largest buyer was Fidelity International, adding an estimated $77.8M. The largest seller was Wellington Management Group, cutting an estimated $41M.
- 334 institutional investors held Bausch Health (BHC) as of Q4 2018, up from 332 in Q3 2018.
- Funds reported $3.54B of Bausch Health stock for Q4 2018, down 23% quarter-over-quarter.
- 60 funds opened new Bausch Health positions in Q4 2018 and 55 closed out, a net change of +5 holders.
- The largest Bausch Health buyer in Q4 2018 was Fidelity International, an estimated $77.8M added.
- The largest Bausch Health seller in Q4 2018 was Wellington Management Group, an estimated $41M sold.
Based on aggregated 13F filings for Q4 2018.